Drug Shortages

Drug Shortages can occur for many reasons including manufacturing and quality problems, delays, and discontinuations. Manufacturers provide FDA most drug shortage information, and the agency works closely with them to prevent or reduce the impact of shortages.

Shortage notifications and updates may be reported to FDA at drugshortages@fda.hhs.gov.

Drug Shortages Database Get Email Notifications

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Director's Corner Podcasts: Drug Shortages. Dr. Woodcock discusses what the agency is doing to address the issue of drug shortages, and how the agency is working with industry to help lessen their impact.
FDA announces Nov. 27, 2018 public meeting, Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
Statement by FDA Commissioner Scott Gottlieb, M.D., on formation of a new drug shortages task force and FDA’s efforts to advance long-term solutions to prevent shortages
Statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs in FDA’s Center for Drug Evaluation and Research, on the agency’s response to ongoing drug shortages for critical products (6/19/2018)

Lists of Products in Shortage with Extended Use Dates

Influenza Season 2017-2018

Availability of Antiviral Medications (PDF - 39KB) [Updated 3/23/18]

Statement from FDA Commissioner Scott Gottlieb, M.D.

FDA’s work to mitigate shortages of intravenous drugs, shorten supply disruptions and better predict vulnerabilities

For Industry: Send FDA Drug Shortage and Supply Notifications

Industry can notify FDA Drug Shortage Staff via CDER Direct NextGen Portal.

This portal is intended ONLY for drug manufacturers/applicants. Industry can notify the FDA Drug Shortage Staff of new discontinuances, GMP issues, increase in product demand, recalls, supply interruptions, or other events. If you have any questions, please contact: drugshortages@fda.hhs.gov.